Carisma Therapeutics, Inc. (CARM) earnings
CARM earnings moved a median of -0.66% by the close. Quarterly and annual CARM reports and results, each read against the price at its own news timestamp. Back to the CARM overview →
12 measured CARM earnings events.
Where these CARM earnings landedvs 11 measured CARM earnings reactions
| Middle 50% of CARM earnings reactions | -4.63% to +1.17% |
|---|---|
| Median reaction (to close) | -0.66% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 CARM earnings events with a measured close landed between -4.63% and +1.17%; 36% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Carisma Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +12.83% | — | |
| Form 10-Q Carisma Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +0.29% | -2.53% | |
| Form 10-Q Carisma Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +1.32% | +1.53% | |
| Form 10-K/A Carisma Therapeutics For: Dec 31 | SEC filing · Form 10-K | +1.01% | +0.81% | |
| Form 10-K Carisma Therapeutics For: Dec 31 | SEC filing · Form 10-K | -10.40% | -23.17% | |
| Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | -0.46% | -4.63% | |
| Form 10-Q Carisma Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -0.46% | -4.63% | |
| Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights | Press release | +4.89% | +7.26% | |
| Form 10-Q Carisma Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +4.89% | +7.26% | |
| Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights | Press release | -3.29% | -0.66% | |
| Form 10-Q Carisma Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -3.29% | -0.66% | |
| Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights | Press release | -3.56% | -14.40% |
Keep exploring
More CARM: analyst actions → · SEC filings → · CARM overview →